Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

NCT00847379 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy
Becker Muscular Dystrophy

Interventions

DRUG: Ataluren

Sponsor

PTC Therapeutics

Collaborators

[object Object]